載入...
Tissue transglutaminase: a new target to reverse cancer drug resistance
Cancer resistance mechanisms, which result from intrinsic genetic alterations of tumor cells or acquired genetic and epigenetic changes, limit the long-lasting benefits of anti-cancer treatments. Tissue transglutaminase (TG2) has emerged as a putative gene involved in tumor cell drug resistance and...
Na minha lista:
| Main Authors: | , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Vienna
2011
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3535412/ https://ncbi.nlm.nih.gov/pubmed/22130737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00726-011-1167-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|